On July 16, 2021, the board of directors of Sientra, Inc. approved an increase in the size of the Board from seven (7) directors to nine (9) directors and elected Dr. Irina Erenburg and Nori Ebersole as Class II directors of the Board. The Board further determined that Dr. Erenburg would be appointed to the Audit Committee and Nominating & Governance Committee, and that Ms. Ebersole would be appointed to the Compensation Committee and Nominating & Governance Committee. Dr. Erenburg, age 51, has served as Founder, President & CEO of Blossom Innovations, LLC, since 2013. Ms. Ebersole, age 57, has served as the Chief People Officer at Prometheus Biosciences, Inc. since April 2021.
Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
SIENTRA, INC. 
